Therefore, molecules targeting SERPINA3 or maybe other serpins may have therapeutic implications for melanoma in the near future, although the precise mechanism of how SERPINA3, the serine protease inhibitor, affects the structure of ECM remains to be elucidated. This evidence concerns the gene SERPINA3 and melanoma.